The effects of statins on the progression of atherosclerotic renovascular disease

Nephron - Clinical Practice

Volumn 107, Issue 2, 2007, Pages

  Cheung, Ching M ^a   Patel, Amit ^a   Shaheen, Nilam ^a   Cain, Sharon ^b   Eddington, Helen ^a   Hegarty, Janet ^a   Middleton, Rachel J ^a   Cowie, Alistair ^a   Mamtora, Hari ^a   Kalra, Philip A ^a  

^a HOPE HOSPITAL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Atherosclerosis; Progression; Renal artery stenosis; Statin

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DISEASE COURSE; DRUG EFFECT; DRUG MECHANISM; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY ANGIOGRAPHY; KIDNEY ARTERY STENOSIS; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROTEINURIA; RENAL ARTERY; RENOVASCULAR DISEASE; RISK FACTOR;

ADULT; AGED; ATHEROSCLEROSIS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KIDNEY DISEASES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 35048881060     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107552     Document Type: Article

References (20)

1. Mailloux LU, Napolitano B, Bellucci AG, Vernace M, Wilkes BM, Mossey RT: Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience. Am J Kidney Dis 1994;24:622-629.
2. Pickering TG, Herman L, Devereux RB, Sotelo JE, James GD, Sos TA, Silane MF, Laragh JH: Recurrent pulmonary oedema in hypertension due to bilateral renal artery stenosis: treatment by angioplasty or surgical revascularisation. Lancet 1988;2:551-552.
3. Shurrab AE, MacDowall P, Wright J, Mamtora H, Kalra PA: The importance of associated extra-renal vascular disease on the outcome of patients with atherosclerotic renovascular disease. Nephron Clin Pract 2003;93:C51-C57.
4. Schreiber MJ, Pohl MA, Novick AC: The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am 1984;11:383-392.
5. Zierler RE, Bergelin RO, Davidson RC, Cantwell-Gab K, Polissar NL, Strandness DE Jr: A prospective study of disease progression in patients with atherosclerotic renal artery stenosis. Am J Hypertens 1996;9:1055-1061.
6. Caps MT, Perissinotto C, Zierler RE, Polissar NL, Bergelin RO, Tullis MJ, Cantwell-Gab K, Davidson RC, Strandness DE Jr: Prospective study of atherosclerotic disease progression in the renal artery. Circulation 1998;98:2866-2872.
7. Nissen SE: Halting the progression of atherosclerosis with intensive lipid lowering: results from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial. Am J Med 2005;118(suppl 12A):22-27.
8. de Groot E, Jukema JW, van Boven AJ, Reiber JH, Zwinderman AH, Lie KI, Ackerstaff RA, Bruschke AV: Effect of pravastatin on progression and regression of coronary atherosclerosis and vessel wall changes in carotid and femoral arteries: a report from the Regression Growth Evaluation Statin Study. Am J Cardiol 1995;76:40C-46C.
9. Khong TK, Missouris CG, Belli AM, MacGregor GA: Regression of atherosclerotic renal artery stenosis with aggressive lipid lowering therapy. J Hum Hypertens 2001;15:431-433.
10. Makanjuola AD, Suresh M, Laboi P, Kalra PA, Scoble JE: Proteinuria in atherosclerotic renovascular disease. QJM 1999;92:515-518.
11. Miettinen H, Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke 1996;27:2033-2039.
12. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A: Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989;32:219-226.
13. Stehouwer CD, Nauta JJ, Zeldenrust GC, Hackeng WH, Donker AJ, den Ottolander GJ: Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 1992;340:319-323.
14. Ehrenstein MR, Jury EC, Mauri C: Statins for atherosclerosis - as good as it gets? N Engl J Med 2005;352:73-75.
15. Fried LF, Orchard TJ, Kasiske BL: Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int 2001;59:260-269.
16. Chade AR, Rodriguez-Porcel M, Grande JP, Zhu X, Sica V, Napoli C, Sawamura T, Textor SC, Lerman A, Lerman LO: Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis. Arterioscler Thromb Vasc Biol 2003;23:1295-1301.
17. Cheung CM, Wright JR, Shurrab AE, Mamtora H, Foley RN, O'Donoghue DJ, Waldek S, Kalra PA: Epidemiology of renal dysfunction and patient outcome in atherosclerotic renal artery occlusion. J Am Soc Nephrol 2002;13:149-157.
18. Wright JR, Shurrab AE, Cheung C, Waldek S, O'Donoghue DJ, Foley RN, Mamtora H, Kalra PA: A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease. Am J Kidney Dis 2002;39:1153-1161.
19. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D: Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham Heart Study. Circulation 1999;100:354-360.
20. Witteman JC, Grobbee DE, Valkenburg HA, van Hemert AM, Stijnen T, Burger H, Hofman A: J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis. Lancet 1994;343:504-507.